July 2026 - Australian healthcare company invests $1.39 million for 10.2% of molecular diagnostics firm to expand market reach and product synergy.

July 2026 - ASX-listed BCAL Diagnostics invests $1.39 million for 10.2% of molecular diagnostics firm, aiming to expand market reach and leverage complementary capabilities.

Arizona is boosting its defenses against the New World screwworm as the deadly parasite threatens U.S. livestock again.

Scientists say it has the potential to extend lives by helping doctors identify patients whose disease is more likely to ...

NCCN now recognizes personalized, tumor-informed ctDNA-MRD as a prognostic and predictive biomarker in MIBC, extending ...

Mucor PCR testing of bronchoalveolar lavage (BAL) fluid showed high specificity in identifying invasive pulmonary mucormycosis (IPM) in lung transplant recipients, especially when used in conjunction ...

The agency cleared more than a dozen assays and instruments for microbiology, molecular biology, clinical chemistry, and other testing.

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces expanded availability of Precise MRD™, broadening availability to patients ...

GENE-UP TYPER SLM is a new real-time PCR solution supporting rapid root cause analysis by discriminating Salmonella in food ...

(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that a delegation from ...

As millions of soccer fans pack FIFA World Cup venues, public health scientists created a wastewater monitoring network to forecast potential disease threats—from measles to Ebola ...

The enzyme RNA polymerase (RNAP) carries out transcription, copying DNA into RNA. It's the first step in gene expression, and a process fundamental to all life. But the inner workings of this ...